Cerus vs Si-Bone
CERS and SIBN side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CERS and SIBN compare
Si-Bone is the larger company, worth 2.6 times as much as Cerus ($1.1B against $427M).
Cerus keeps more of each dollar of sales as profit, with a net margin of −2.9% compared with −6.9% at Si-Bone.
Si-Bone scores higher on the StockData Score (11 against 6 for Cerus), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CERS | SIBN |
|---|---|---|
| Size and price | ||
| Market cap | $427M | $1.1B |
| Share price | $2.12 | $24.94 |
| Change, 1 year | 32.5% | 59.1% |
| Change, 5 years | −70.6% | 17.4% |
| Beta (5Y) | 1.72 | 0.81 |
| Employees | 275 | 376 |
| StockData Score | ||
| Total score | 6 | 11 (better) |
| Valuation score | 2 (better) | 0 |
| Growth score | 0 | 4 (better) |
| Performance score | 3 | 3 |
| Health score | 1 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.7× (better) | 5.2× |
| P/B | 5.6× (better) | 6.1× |
| P/FCF | 865× | – |
| FCF yield | 0.12% (better) | −0.39% |
| Fair value | $2.72 | $16.48 |
| Margin of safety | 22.1% (better) | −51.4% |
| Growth | ||
| Revenue growth (TTM) | – | 15.3% |
| Revenue growth, 5Y average | 15.4% | 22.3% (better) |
| Profitability | ||
| Gross margin | – | 79.5% |
| Operating margin | −0.97% (better) | −8.3% |
| Net margin | −2.9% (better) | −6.9% |
| FCF margin | 0.19% (better) | −2.1% |
| Return on equity | −10.7% | −8.3% (better) |
| Return on invested capital | −966% | −19.6% (better) |
| Financial health | ||
| Debt / equity | – | 0.20 |
| Interest coverage | −0.4× (better) | −7.1× |
| Current ratio | 1.96 | 9.15 (better) |
| Altman Z-score | −3.78 | 9.09 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.00% |
| Years of dividend growth | – | 0 |
| Buyback yield | 0.01% | – |
| Shareholder yield | 0.01% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 74.8% | 108% |
| Held by insiders | 6.0% | 3.7% |
| Insider net buying, 12 months | −$3.2M (better) | −$14.6M |
| Short interest, % of float | 7.7% | 10.5% |
Go deeper
- CERS stock overview
- CERS income statement
- CERS valuation and score
- SIBN stock overview
- SIBN income statement
- SIBN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.